Late development of resistance to BRAF/MEK inhibitors in malignant melanoma: a case report

被引：0
|
作者：
Adam, C. [1 ]
Meier, F. [1 ]
Garzarolli, M. [1 ]
机构：
[1] Uniklinikum Dresden, Dresden, Germany
来源：
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT | 2023年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
eP085
引用
收藏
页码：81 / 81
页数：1
相关论文
共 50 条
  • [1] Resistance to BRAF and MEK inhibitors in BRAF-mutant melanoma
    Patel, Hima
    Yacoub, Nour
    Garrett, Joan T.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) : AB43 - AB43
  • [2] Overcoming the resistance to BRAF inhibitor by the double BRAF and MEK inhibitions in advanced melanoma: a case report
    Kattan, Joseph
    Kattan, Clarisse
    Farhat, Fadi
    Assi, Tarek
    ANTI-CANCER DRUGS, 2019, 30 (10) : 1052 - 1054
  • [3] Palbociclib synergizes with BRAF and MEK inhibitors in treatment naive melanoma but not after the development of BRAF inhibitor resistance
    Martin, Claire A.
    Cullinane, Carleen
    Kirby, Laura
    Abuhammad, Shatha
    Lelliott, Emily J.
    Waldeck, Kelly
    Young, Richard J.
    Brajanovski, Natalie
    Cameron, Donald P.
    Walker, Rachael
    Sanij, Elaine
    Poortinga, Gretchen
    Hannan, Ross D.
    Pearson, Richard B.
    Hicks, Rodney J.
    McArthur, Grant A.
    Sheppard, Karen E.
    INTERNATIONAL JOURNAL OF CANCER, 2018, 142 (10) : 2139 - 2152
  • [4] BRAF and MEK resistance in melanoma
    Herlyn, Meenhard
    Villanueva, Jessie
    CLINICAL CANCER RESEARCH, 2012, 18 (10)
  • [5] A Predictive Model of Adaptive Resistance to BRAF/MEK Inhibitors in Melanoma
    Ruiz, Emmanuelle M.
    Alhassan, Solomon A.
    Errami, Youssef
    Abd Elmageed, Zakaria Y.
    Fang, Jennifer S.
    Wang, Guangdi
    Brooks, Margaret A.
    Abi-Rached, Joe A.
    Kandil, Emad
    Zerfaoui, Mourad
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (09)
  • [6] Concurrent MEK2 Mutation and BRAF Amplification Confer Resistance to BRAF and MEK Inhibitors in Melanoma
    Villanueva, Jessie
    Infante, Jeffrey R.
    Krepler, Clemens
    Reyes-Uribe, Patricia
    Samanta, Minu
    Chen, Hsin-Yi
    Li, Bin
    Swoboda, Rolf K.
    Wilson, Melissa
    Vultur, Adina
    Fukunaba-Kalabis, Mizuho
    Wubbenhorst, Bradley
    Chen, Thomas Y.
    Liu, Qin
    Sproesser, Katrin
    DeMarini, Douglas J.
    Gilmer, Tona M.
    Martin, Anne-Marie
    Marmorstein, Ronen
    Schultz, David C.
    Speicher, David W.
    Karakousis, Giorgos C.
    Xu, Wei
    Amaravadi, Ravi K.
    Xu, Xiaowei
    Schuchter, Lynn M.
    Herlyn, Meenhard
    Nathanson, Katherine L.
    CELL REPORTS, 2013, 4 (06): : 1090 - 1099
  • [7] Impact of BRAF and MEK Inhibitors on Gingival Hyperplasia in Melanoma Patients-A Case Report
    Veljovic, Tanja
    Djuric, Milanko
    Gusic, Ivana
    Vuckovic, Nada
    Ramic, Bojana
    Mirnic, Jelena
    JOURNAL OF CLINICAL MEDICINE, 2025, 14 (01)
  • [8] Uveitis associated with immune checkpoint inhibitors or BRAF/MEK inhibitors in patients with malignant melanoma
    Sada, Ikuyo
    Harada, Yosuke
    Hiyama, Tomona
    Mizukami, Mina
    Kan, Takanobu
    Kawai, Mikio
    Kiuchi, Yoshiaki
    MELANOMA RESEARCH, 2023, 33 (06) : 539 - 546
  • [9] Growth factor-mediated resistance to BRAF/MEK inhibitors in BRAF mutant melanoma
    Lutterbach, Bart
    Ware, Chris
    Davis, Lenora
    Zhang, Qing
    Zawel, Leigh
    Reilly, John
    Pan, Bo-Sheng
    CANCER RESEARCH, 2012, 72
  • [10] BRAF and MEK inhibitors in BRAF-mutant melanoma
    Sharma, Sharan Prakash
    LANCET ONCOLOGY, 2012, 13 (11): : E468 - E468
12345